A path plagued by progression: The chronic kidney disease journey
Chronic kidney disease (CKD) is known as a “silent disease” because as many as 90% of patients...
Chronic kidney disease (CKD) is known as a “silent disease” because as many as 90% of patients...
As therapies become increasingly complex and personalized, it is imperative that physicians...
While each rare disease individually impacts only 200,000 people or less, with 7,000 known rare...
As life settles into the new normal after the worst of the COVID-19 pandemic, it is clear that...
Historically, clinical trial data and real-world data (RWD) have existed in silos. With increasing...
A recent survey by the Deloitte Center for Health Solutions of biopharma executives and other...
Diabetes is a complex disease that affects over 37 million Americans, or 11% of the population, and...
Written by Emery Niemiec, Director, Partners & Alliance at HealthVerity I had the pleasure of...
The Inside Story Behind MOM, the Maternal Outcomes Masterset In the Spring of 2021, HealthVerity...
Written by Emery Niemiec I recently attended the 2022 INFORMS Business Analytics Conference and had...
The problem with Zombie Data—And the critical need for Verified Data In life sciences, where real-world data (RWD) fuels research, market access, and commercial decision-making, trust in data is everything. Yet, the growing presence of Zombie Data—da...